Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

1.2K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
1.2K
The Evidence for Evolution02:55

The Evidence for Evolution

48.4K
Genetic variations accumulating within populations over generations give rise to biological evolution. Evolutionary changes can result in the formation of novel varieties and entire new species. These changes are responsible for the diverse forms of life inhabiting the planet. The evidence for evolution suggests that all living organisms descended from common ancestors.
48.4K
Types of Toxins01:36

Types of Toxins

3.7K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.7K
Intrinsically Disordered Proteins02:18

Intrinsically Disordered Proteins

19.6K
Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
19.6K
What is Natural Selection?01:32

What is Natural Selection?

129.9K
Natural selection is an evolutionary process in which individuals with survival-promoting traits reproduce at higher rates. These favorable traits become more common within a population or species. Naturally selected traits initially arise via random genetic mutations. In order for selection to occur, there must be variation within a population, the trait controlling the variation must be heritable, and there must be an evolutionary advantage for variation in the trait.
129.9K
Antibiotic Selection00:57

Antibiotic Selection

60.3K
Overview
60.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathways of Inequality: Impact of Community Violence Exposure on Internalizing Behavior Among African American, Latinx, and White Youth.

Journal of community psychology·2026
Same author

Correction: Tamayo et al. Botulinum Toxin in Pain-Related Post-Stroke Limb Spasticity: A Meta-Analysis of Early and Late Injections. <i>Toxins</i> 2025, <i>17</i>, 258.

Toxins·2026
Same author

Use and preferences of advanced driver assistance systems by drivers with homonymous visual field loss.

Disability and rehabilitation. Assistive technology·2026
Same author

Real-world driving behaviors in individuals with homonymous visual field loss: insights from a naturalistic driving study.

Accident; analysis and prevention·2026
Same author

Pre-training practices and contextual determinants of trauma-informed care among community members and youth-serving providers.

Journal of prevention & intervention in the community·2026
Same author

Editorial: TOXINS 2026: 8th International Conference.

Toxicon : official journal of the International Society on Toxinology·2025

Related Experiment Video

Updated: Feb 14, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
07:05

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

24.9K

Evidence on botulinum toxin in selected disorders.

Elina Zakin1, David Simpson1

  • 1Department of Neuromuscular Medicine, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.

Toxicon : Official Journal of the International Society on Toxinology
|February 7, 2018
PubMed
Summary

Botulinum toxin (BoNT) offers symptomatic relief for neurologic disorders like blepharospasm, cervical dystonia, spasticity, and chronic migraine. Evidence supports specific BoNT formulations for each condition, aiding clinical decision-making in treatment.

Keywords:
BlepharospasmBoNTCervical dystoniaChronic migraineLimb spasticity

More Related Videos

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

9.0K
Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
12:25

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

16.6K

Related Experiment Videos

Last Updated: Feb 14, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
07:05

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

24.9K
A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

9.0K
Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
12:25

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

16.6K

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Botulinum toxin (BoNT) is a neurotoxin from Clostridium botulinum.
  • Four BoNT formulations are FDA-approved in the US: onabotulinumtoxinA, abobotulinumtoxinA, incobotulinumtoxinA, and rimabotulinumtoxinB.
  • While labels advise against potency conversions, literature suggests dose equivalents.

Purpose of the Study:

  • To review evidence for US-available BoNT formulations in specific neurologic disorders.
  • To present data from the 2016 American Academy of Neurology (AAN) guidelines.
  • To discuss the level of evidence for each BoNT preparation.

Main Methods:

  • Literature review of BoNT formulations for neurologic indications.
  • Analysis of 2016 AAN guidelines.
  • Evidence grading for BoNT use in blepharospasm, cervical dystonia, spasticity, and chronic migraine.

Main Results:

  • Level B evidence supports onabotulinumtoxinA and incobotulinumtoxinA for blepharospasm.
  • Level A evidence supports abobotulinumtoxinA and rimabotulinumtoxinB for cervical dystonia.
  • Level A evidence supports various BoNT formulations for upper/lower extremity spasticity and chronic migraine (onabotulinumtoxinA).

Conclusions:

  • BoNT formulations have specific evidence-based recommendations for various neurologic conditions.
  • Clinicians should use BoNT for symptomatic control, not disease modification.
  • Understanding formulation-specific evidence is crucial for effective patient management.